SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 138 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $2,261,000 | -3.8% | 205,529 | +18.5% | 0.61% | -9.1% |
Q4 2016 | $2,350,000 | +1019.0% | 173,457 | +801.9% | 0.67% | +750.6% |
Q1 2016 | $210,000 | -15.3% | 19,232 | +33.9% | 0.08% | -31.9% |
Q4 2015 | $248,000 | -30.7% | 14,360 | -72.3% | 0.12% | -49.8% |
Q2 2014 | $358,000 | -61.9% | 51,882 | -48.0% | 0.23% | -8.0% |
Q4 2013 | $939,000 | +135.3% | 99,846 | +56.2% | 0.25% | +118.3% |
Q3 2013 | $399,000 | +28.7% | 63,936 | +35.7% | 0.12% | +19.8% |
Q2 2013 | $310,000 | – | 47,112 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 1,304,376 | $23,414,000 | 7.30% |
Kassirer Asset Management Corp | 291,784 | $5,238,000 | 5.39% |
First Trust Capital Management L.P. | 637,578 | $11,445,000 | 2.19% |
NEXTHERA CAPITAL LP | 510,486 | $9,163,000 | 1.69% |
HAVENS ADVISORS LLC | 100,000 | $1,795,000 | 1.35% |
Piermont Capital Management Inc. | 172,980 | $3,105,000 | 1.02% |
PRELUDE CAPITAL MANAGEMENT, LLC | 674,446 | $12,106,000 | 0.97% |
ALPINE ASSOCIATES MANAGEMENT INC. | 1,495,600 | $26,845,000 | 0.96% |
LONGFELLOW INVESTMENT MANAGEMENT CO LLC | 200,000 | $3,590,000 | 0.87% |
BOOTHBAY FUND MANAGEMENT, LLC | 332,075 | $5,961,000 | 0.87% |